These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37404865)

  • 1. How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints.
    Perry B; Kehoe L; Swezey T; Le Masne Q; Goldhahn J; Staley A; Corneli A
    Digit Biomark; 2023; 7(1):45-53. PubMed ID: 37404865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms.
    Marra C; Stern AD
    Clin Pharmacol Ther; 2024 May; 115(5):988-992. PubMed ID: 38308421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Health Technology (DHT) in European Clinical Trials, How to Improve the Status-Quo of the Regulatory Landscape?
    Podhaisky HP
    Ther Innov Regul Sci; 2024 Jul; 58(4):610-613. PubMed ID: 38656468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital health technology derived measures: Biomarkers or clinical outcome assessments?
    Izmailova ES; Demanuele C; McCarthy M
    Clin Transl Sci; 2023 Jul; 16(7):1113-1120. PubMed ID: 37118983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital technologies: Innovations that transform the face of drug development.
    Izmailova ES; AbuAsal B; Hassan HE; Saha A; Stephenson D
    Clin Transl Sci; 2023 Aug; 16(8):1323-1330. PubMed ID: 37157935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons for Vietnam on the Use of Digital Technologies to Support Patient-Centered Care in Low- and Middle-Income Countries in the Asia-Pacific Region: Scoping Review.
    Kosowicz L; Tran K; Khanh TT; Dang TH; Pham VA; Ta Thi Kim H; Thi Bach Duong H; Nguyen TD; Phuong AT; Le TH; Ta VA; Wickramasinghe N; Schofield P; Zelcer J; Pham Le T; Nguyen TA
    J Med Internet Res; 2023 Apr; 25():e43224. PubMed ID: 37018013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies.
    Hey SP; Dellapina M; Lindquist K; Hartog B; LaRoche J
    Ther Innov Regul Sci; 2023 Nov; 57(6):1269-1278. PubMed ID: 37544966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Tools-Regulatory Considerations for Application in Clinical Trials.
    Gelis L; Stoeckert I; Podhaisky HP
    Ther Innov Regul Sci; 2023 Jul; 57(4):769-782. PubMed ID: 37195515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Novel Measurement of Sleep in Rheumatoid Arthritis: Study Proposal for Approach and Considerations.
    Crouthamel M; Mather RJ; Ramachandran S; Bode K; Chatterjee G; Garcia-Gancedo L; Kim J; Alaj R; Wipperman MF; Leyens L; Sillen H; Murphy T; Benecky M; Maggio B; Switzer T
    Digit Biomark; 2021; 5(3):191-205. PubMed ID: 34703974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations to address missing data when deriving clinical trial endpoints from digital health technologies.
    Di J; Demanuele C; Kettermann A; Karahanoglu FI; Cappelleri JC; Potter A; Bury D; Cedarbaum JM; Byrom B
    Contemp Clin Trials; 2022 Feb; 113():106661. PubMed ID: 34954098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Meaningful Outcomes to Meaningful Change Thresholds: A Path to Progress for Establishing Digital Endpoints.
    Mc Carthy M; Burrows K; Griffiths P; Black PM; Demanuele C; Karlsson N; Buenconsejo J; Patel N; Chen WH; Cappelleri JC
    Ther Innov Regul Sci; 2023 Jul; 57(4):629-645. PubMed ID: 37020160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of economic, educational and social resources in supporting the use of digital health technologies by people with T2D: a qualitative study.
    Turnbull S; Lucas PJ; Hay AD; Cabral C
    BMC Public Health; 2021 Feb; 21(1):293. PubMed ID: 33546661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities for digital health technology: identifying unmet needs for bipolar misdiagnosis and depression care management.
    Kark SM; Worthington MA; Christie RH; Masino AJ
    Front Digit Health; 2023; 5():1221754. PubMed ID: 37771820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider- and Patient-Related Barriers to and Facilitators of Digital Health Technology Adoption for Hypertension Management: Scoping Review.
    Palacholla RS; Fischer N; Coleman A; Agboola S; Kirley K; Felsted J; Katz C; Lloyd S; Jethwani K
    JMIR Cardio; 2019 Mar; 3(1):e11951. PubMed ID: 31758771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
    Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
    Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.
    ; ;
    Health Qual Life Outcomes; 2006 Oct; 4():79. PubMed ID: 17034633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.
    Morrow RL; Mintzes B; Gray G; Law MR; Garrison S; Dormuth CR
    Clin Ther; 2022 Mar; 44(3):374-388. PubMed ID: 34955232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and Challenges to Advance Health Equity Using Digital Health Tools in Underserved Communities in Southeast US: A Mixed Methods Study.
    Blount MA; Douglas MD; Li C; Walston DT; Nelms PL; Hughes CL; Gaglioti AH; Mack DH
    J Prim Care Community Health; 2023; 14():21501319231184789. PubMed ID: 37401631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes.
    Piette JD; Lee KCS; Bosworth HB; Isaacs D; Cerrada CJ; Kainkaryam R; Liska J; Lee F; Kennedy A; Kerr D
    Transl Behav Med; 2024 Jul; ():. PubMed ID: 38953616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
    Boesen K; Gøtzsche PC; Ioannidis JPA
    Epidemiol Psychiatr Sci; 2021 Apr; 30():e35. PubMed ID: 33926608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.